Does Rallies show Form 4 insider transactions for HNGE?

Yes. Rallies tracks HNGE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.

Is HNGE research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HNGE. It does not provide personalized investment advice.

HNGE (Hinge Health, Inc.) Stock Analysis - Insider Trades

Hinge Health, Inc. (HNGE) is a publicly traded Healthcare sector company. As of May 21, 2026, HNGE trades at $55.84 with a market cap of $4.23B and a P/E ratio of -5.08. HNGE moved -0.64% today. Year to date, HNGE is +16.77%; over the trailing twelve months it is flat. Its 52-week range spans $30.08 to $62.18. Analyst consensus is strong buy with an average price target of $68.15. Rallies surfaces HNGE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who is trading HNGE stock inside the company?

Recent HNGE insider activity includes Budge James sold 4.71K, Budge James sold 1.20K, Perez Daniel Antonio sold 45.46K, Mecklenburg Gabriel M.I. sold 50.00K, and Perez Daniel Antonio sold 104.54K. Rallies tracks insider transaction dates, shares, prices, and estimated values.

HNGE Key Metrics

Key financial metrics for HNGE
Metric	Value
Price	$55.84
Market Cap	$4.23B
P/E Ratio	-5.08
EPS	$-10.58
Dividend Yield	0.00%
52-Week High	$62.18
52-Week Low	$30.08
Volume	568
Avg Volume	0
Revenue (TTM)	$646.34M
Net Income	$-510.27M
Gross Margin	80.80%

Recent HNGE Insider Trades

Budge James sold 4.71K (~$257.19K) on May 11, 2026.
Budge James sold 1.20K (~$66.57K) on May 11, 2026.
Perez Daniel Antonio sold 45.46K (~$2.50M) on May 7, 2026.
Mecklenburg Gabriel M.I. sold 50.00K (~$2.75M) on May 6, 2026.
Perez Daniel Antonio sold 104.54K (~$5.76M) on May 6, 2026.

Latest HNGE News

Analysts See 39% Upside in Hinge Health as EPS Estimates Climb 63% — Feb 20, 2026
Hinge Health Jumps 17% on 50.7% Revenue Growth and 25% 2026 Guidance — Feb 12, 2026
Hinge Health Report Finds Treatment Gaps in 1,000-Patient MSK Study — Jan 15, 2026

HNGE Analyst Consensus

13 analysts cover HNGE: 0 strong buy, 13 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $68.15.

Common questions about HNGE

Who is trading HNGE stock inside the company?: Recent HNGE insider activity includes Budge James sold 4.71K, Budge James sold 1.20K, Perez Daniel Antonio sold 45.46K, Mecklenburg Gabriel M.I. sold 50.00K, and Perez Daniel Antonio sold 104.54K. Rallies tracks insider transaction dates, shares, prices, and estimated values.
Does Rallies show Form 4 insider transactions for HNGE?: Yes. Rallies tracks HNGE insider trading and Form 4 activity, including executive purchases, executive sales, transaction dates, shares, and prices when available.
Is HNGE research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HNGE. It does not provide personalized investment advice.